跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Qlaira - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Qlaira
Approved
STANDARD
Qlaira
Bayer Weimar GmbH und Co. KG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5583a0fbf9585e81
Company
Bayer Weimar GmbH und Co. KG
Type
Standard
Approval Details
Approval Id
5583a0fbf9585e81
Drug Approval Philippines Name
Qlaira
Product Name
Qlaira
Registration Number
DR-XY38455
Brand Name
Qlaira
Generic Name
Estradiol Valerate + Dienogest
Dosage Form
Film-Coated Tablet
Dosage Strength
complete formulation on reverse side o
Manufacturer
Bayer Weimar GmbH und Co. KG
Importer
Bayer Philippines, Inc.
Distributor
Bayer Philippines, Inc.
Company Detail Path
/organization/bayer-weimar-gmbh-und-co-kg
Issuance Date
25 May 2023
Expiry Date
16 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5583a0fbf9585e81
Type
Standard
Back to Philippines FDA Approvals